Shopping Cart 0
Cart Subtotal
USD 0

QIMR Berghofer Medical Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

QIMR Berghofer Medical Research Institute (QIMR), formerly Queensland Institute of Medical Research is a medical research institute that offers education and research programs. The institute offers its research programs in the areas of mental health, cancer, infectious disease, and complex disorders. Its cancer research areas includes breast cancer, blood cancer, brain cancer, lung cancer, endometrial cancer, melanoma, nasopharyngeal carcinoma, pancreatic cancer, prostate cancer, ovarian cancer, and stomach cancer, among others. QIMR offers services such as project development, management, budgeting and research contracts, and intellectual property identification, protection and commercialisation services. The institute also provides technology transfers, clinical trials, and contract research and development services. QIMR is headquartered in Brisbane, Queensland, Australia.

QIMR Berghofer Medical Research Institute-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

QIMR Berghofer Medical Research Institute, Medical Devices Deals, 2012 to YTD 2018 9

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Invenra Enters into Agreement with QIMR Berghofer Medical Research Institute 11

Licensing Agreements 12

Atara Biotherapeutics Amends Licensing Agreement with QIMR Berghofer 12

Bristol-Myers Squibb Enters into Licensing Agreement with QIMR Berghofer Medical Research Institute 13

QIMR Berghofer Medical Research Institute-Key Competitors 14

QIMR Berghofer Medical Research Institute-Key Employees 15

QIMR Berghofer Medical Research Institute-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 17

Strategy And Business Planning 17

Jul 04, 2018: Leading clinical trials company expands for the future 17

Nov 29, 2017: ACRF grant to transform Queensland into global immunotherapy hub 18

Government and Public Interest 19

Jun 25, 2018: Major Study Uncovers New Breast Cancer Genes And Opens The Door For More Discoveries 19

May 10, 2018: Researchers uncover how infant viral infections become childhood asthma 20

May 09, 2018: Global genetic study of skin colour unearths 14 new genetic markers 22

Apr 16, 2018: New biomarker for prostate cancer could help guide treatment pathways 23

Mar 27, 2018: Australian vaccine innovation set to strike out zika and chikungunya in one go 25

Mar 16, 2018: Scientists identify new possibility for untreatable blood cancer 27

Feb 13, 2018: Researchers build tiny DNA nanorobots to block cancer growth 29

Jan 02, 2018: Scientists solve puzzle of why some children with cystic fibrosis sustain liver damage 31

Nov 29, 2017: Australian Cancer Research Foundation Awards USD 7.5 Million To Accelerate Cancer Research Across Australia 33

Nov 13, 2017: Research uncovers potential new approach for treating asthma 34

Aug 08, 2017: Researchers Identify Two New Breast Cancer Genes 35

Jul 20, 2017: Gene Discovery to Help Breast Cancer Patients 36

Product News 37

Jul 06, 2018: Hope for transplant patients after world-first Queensland immunotherapy trial 37

Jul 02, 2018: Queensland researchers design clinical trial model that could eradicate malaria 38

Other Significant Developments 40

Jul 30, 2018: Researchers identify 40 new genetic markers for glaucoma 40

Appendix 42

Methodology 42

About GlobalData 42

Contact Us 42

Disclaimer 42


List Of Figure

List of Figures

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

QIMR Berghofer Medical Research Institute, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Key Facts 2

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

QIMR Berghofer Medical Research Institute, Deals By Therapy Area, 2012 to YTD 2018 8

QIMR Berghofer Medical Research Institute, Medical Devices Deals, 2012 to YTD 2018 9

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Invenra Enters into Agreement with QIMR Berghofer Medical Research Institute 11

Atara Biotherapeutics Amends Licensing Agreement with QIMR Berghofer 12

Bristol-Myers Squibb Enters into Licensing Agreement with QIMR Berghofer Medical Research Institute 13

QIMR Berghofer Medical Research Institute, Key Competitors 14

QIMR Berghofer Medical Research Institute, Key Employees 15

QIMR Berghofer Medical Research Institute, Other Locations 16

QIMR Berghofer Medical Research Institute, Subsidiaries 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

QIMR Berghofer Medical Research Institute, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

QIMR Berghofer Medical Research Institute (QIMR), formerly Queensland Institute of Medical Research is a medical research institute that offers education and research programs. The institute offers its research programs in the areas of mental health, cancer, infectious disease, and complex disorders. Its cancer research areas includes breast cancer, blood cancer, brain cancer, lung cancer, endometrial cancer, melanoma, nasopharyngeal carcinoma, pancreatic cancer, prostate cancer, ovarian cancer, and stomach cancer, among others. QIMR offers services such as project development, management, budgeting and research contracts, and intellectual property identification, protection and commercialisation services. The institute also provides technology transfers, clinical trials, and contract research and development services. QIMR is headquartered in Brisbane, Queensland, Australia.

QIMR Berghofer Medical Research Institute-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

QIMR Berghofer Medical Research Institute, Medical Devices Deals, 2012 to YTD 2018 9

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Invenra Enters into Agreement with QIMR Berghofer Medical Research Institute 11

Licensing Agreements 12

Atara Biotherapeutics Amends Licensing Agreement with QIMR Berghofer 12

Bristol-Myers Squibb Enters into Licensing Agreement with QIMR Berghofer Medical Research Institute 13

QIMR Berghofer Medical Research Institute-Key Competitors 14

QIMR Berghofer Medical Research Institute-Key Employees 15

QIMR Berghofer Medical Research Institute-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 17

Strategy And Business Planning 17

Jul 04, 2018: Leading clinical trials company expands for the future 17

Nov 29, 2017: ACRF grant to transform Queensland into global immunotherapy hub 18

Government and Public Interest 19

Jun 25, 2018: Major Study Uncovers New Breast Cancer Genes And Opens The Door For More Discoveries 19

May 10, 2018: Researchers uncover how infant viral infections become childhood asthma 20

May 09, 2018: Global genetic study of skin colour unearths 14 new genetic markers 22

Apr 16, 2018: New biomarker for prostate cancer could help guide treatment pathways 23

Mar 27, 2018: Australian vaccine innovation set to strike out zika and chikungunya in one go 25

Mar 16, 2018: Scientists identify new possibility for untreatable blood cancer 27

Feb 13, 2018: Researchers build tiny DNA nanorobots to block cancer growth 29

Jan 02, 2018: Scientists solve puzzle of why some children with cystic fibrosis sustain liver damage 31

Nov 29, 2017: Australian Cancer Research Foundation Awards USD 7.5 Million To Accelerate Cancer Research Across Australia 33

Nov 13, 2017: Research uncovers potential new approach for treating asthma 34

Aug 08, 2017: Researchers Identify Two New Breast Cancer Genes 35

Jul 20, 2017: Gene Discovery to Help Breast Cancer Patients 36

Product News 37

Jul 06, 2018: Hope for transplant patients after world-first Queensland immunotherapy trial 37

Jul 02, 2018: Queensland researchers design clinical trial model that could eradicate malaria 38

Other Significant Developments 40

Jul 30, 2018: Researchers identify 40 new genetic markers for glaucoma 40

Appendix 42

Methodology 42

About GlobalData 42

Contact Us 42

Disclaimer 42


List Of Figure

List of Figures

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

QIMR Berghofer Medical Research Institute, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Key Facts 2

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

QIMR Berghofer Medical Research Institute, Deals By Therapy Area, 2012 to YTD 2018 8

QIMR Berghofer Medical Research Institute, Medical Devices Deals, 2012 to YTD 2018 9

QIMR Berghofer Medical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Invenra Enters into Agreement with QIMR Berghofer Medical Research Institute 11

Atara Biotherapeutics Amends Licensing Agreement with QIMR Berghofer 12

Bristol-Myers Squibb Enters into Licensing Agreement with QIMR Berghofer Medical Research Institute 13

QIMR Berghofer Medical Research Institute, Key Competitors 14

QIMR Berghofer Medical Research Institute, Key Employees 15

QIMR Berghofer Medical Research Institute, Other Locations 16

QIMR Berghofer Medical Research Institute, Subsidiaries 16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

QIMR Berghofer Medical Research Institute, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat